Efficient Generation of Cynomolgus Monkey Induced Pluripotent Stem Cell-Derived Intestinal Organoids with Pharmacokinetic Functions

  • Daichi Onozato
    Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Misaki Yamashita
    Faculty of Pharmaceutical Sciences, Educational Research Center for Clinical Pharmacy, Nagoya City University, Nagoya, Japan.
  • Ryosuke Fukuyama
    Faculty of Pharmaceutical Sciences, Educational Research Center for Clinical Pharmacy, Nagoya City University, Nagoya, Japan.
  • Takumi Akagawa
    Faculty of Pharmaceutical Sciences, Educational Research Center for Clinical Pharmacy, Nagoya City University, Nagoya, Japan.
  • Yuriko Kida
    Faculty of Pharmaceutical Sciences, Educational Research Center for Clinical Pharmacy, Nagoya City University, Nagoya, Japan.
  • Akiko Koeda
    Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Tadahiro Hashita
    Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Takahiro Iwao
    Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.
  • Tamihide Matsunaga
    Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Japan.

Search this article

Description

In preclinical studies, the cynomolgus monkey (CM) model is frequently used to predict the pharmacokinetics of drugs in the human small intestine, because of its evolutionary closeness to humans. Intestinal organoids that mimic the intestinal tissue have attracted attention in regenerative medicine and drug development. In this study, we generated intestinal organoids from CM induced pluripotent stem (CMiPS) cells and analyzed their pharmacokinetic functions. CMiPS cells were induced into the hindgut; then, the cells were seeded on microfabricated culture vessel plates to form spheroids. The resulting floating spheroids were differentiated into intestinal organoids in a medium containing small-molecule compounds. The mRNA expression of intestinal markers and pharmacokinetic-related genes was markedly increased in the presence of small-molecule compounds. The organoids possessed a polarized epithelium and contained various cells constituting small intestinal tissues. The intestinal organoids formed functional tight junctions and expressed drug transporter proteins. In addition, in the organoids generated, cytochrome P450 3A8 (CYP3A8) activity was inhibited by the specific inhibitor ketoconazole and was induced by rifampicin. Therefore, in the present work, we successfully generated intestinal organoids, with pharmacokinetic functions, from CMiPS cells using small-molecule compounds.

Journal

Citations (2)*help

See more

References(47)*help

See more

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top